Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Effect of prophylactic cyclosporine therapy on ADAMTS13 biomarkers in patients with idiopathic thrombotic thrombocytopenic purpura.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Effect of prophylactic cyclosporine therapy on ADAMTS13 biomarkers in patients with idiopathic thrombotic thrombocytopenic purpura.
Effect of prophylactic cyclosporine therapy on ADAMTS13 biomarkers in patients with idiopathic thrombotic thrombocytopenic purpura. Am J Hematol. 2008 Dec; 83(12):911-5.
View in:
PubMed
subject areas
ADAM Proteins
ADAM Proteins
ADAMTS13 Protein
ADAMTS13 Protein
Adult
Adult
Autoantibodies
Autoantibodies
Biomarkers
Biomarkers
Cyclosporine
Cyclosporine
Drug Administration Schedule
Drug Administration Schedule
Female
Female
Humans
Humans
Immunosuppressive Agents
Immunosuppressive Agents
Longitudinal Studies
Longitudinal Studies
Male
Male
Middle Aged
Middle Aged
Purpura, Thrombocytopenic, Idiopathic
Purpura, Thrombocytopenic, Idiopathic
Purpura, Thrombotic Thrombocytopenic
Purpura, Thrombotic Thrombocytopenic
Remission Induction
Remission Induction
Secondary Prevention
Secondary Prevention
Young Adult
Young Adult
authors with profiles
James N George